Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials
Journal of Cardiovascular Electrophysiology · 2026-09 · 37 (9) · 2122-2123
DOI: 10.1111/jce.70493 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 03.09.2026. Verfasst von Leonardo M Knijnik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Stroke, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Landmark randomized controlled trials (RCTs) comparing left atrial appendage occlusion (LAAO) against direct oral anticoagulants (DOACs) are individually underpowered for small but clinically meaningful differences. We performed a pooled meta‐analysis to provide more precise efficacy and safety data.
Methods
Utilizing random‐effects models, we pooled data from 5890 patients across four landmark RCTs (PRAGUE‐17, CLOSURE‐AF, OPTION, and CHAMPION‐AF) at their longest follow‐up.
Results
There were no significant differences between LAAO and antithrombotics in cardiovascular mortality (5.3% vs. 4.8%, p = 0.33), all‐cause stroke (3.3% vs. 2.8%, p = 0.31), systemic embolism (0.2% vs. 0.1%, p = 0.68), or major bleeding (6.6% vs. 6.8%, p = 0.85). Non‐procedural bleeding was significantly lower with LAAO (9.2% vs. 16.7%; RR 0.55; 95% CI 0.47–0.64; p < 0.0001), though there was a numerical trend toward more ischemic stroke events (2.7% vs. 2.0%; RR 1.35; 95% CI 0.97–1.88; p = 0.08).
Conclusion
LAAO offers similar overall efficacy and safety to modern antithrombotics. It represents a clinical trade‐off: accepting a known upfront procedural risk for a robust, long‐term reduction in non‐procedural bleeding, potentially at the cost of a slight numerical increase in ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Emory University, Atlanta, Georgia, USA.
ORCID-Profile: Leonardo M Knijnik, Birju Rao
Zitieren
APA
Knijnik, L. M., Rao, B., & DeLurgio, D. B. (2026). Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials. Journal of Cardiovascular Electrophysiology, 37(9), 2122-2123. https://doi.org/10.1111/jce.70493
Vancouver
Knijnik LM, Rao B, DeLurgio DB. Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials. Journal of Cardiovascular Electrophysiology. 2026;37(9):2122-2123. doi:10.1111/jce.70493
BibTeX
@article{Knijnik2026,
author = {Knijnik, Leonardo M and Rao, Birju and DeLurgio, David B},
title = {Pooled Efficacy and Safety of Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulants or Antiplatelets: A Meta‐Analysis of the Landmark Randomized Trials},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {9},
pages = {2122--2123},
doi = {10.1111/jce.70493}
}
EUVIMED